Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine : a randomised, placebo-controlled, first-in-human trial

Source
The lancet : international edition - ISSN 0140-6736-401:10384 (2023) p. 1267-1276
Author(s)
    Roland Tschismarov, Pierre van Damme, Clara Germain, Ilse De Coster, Mathieu Mateo, Stephanie Reynard, Alexandra Journeaux, Yvonne Tomberger, Kanchanamala Withanage, Denise Haslwanter, Katherine Terler, Sabrina Schrauf, Matthias Muellner, Erich Tauber, Katrin Ramsauer, Sylvain Baize

Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study

Source
Vaccine - ISSN 0264-410X-41:10 (2023) p. 1657-1667
Author(s)

Intestinal antibody responses to 2 novel live attenuated type 2 oral poliovirus vaccines in healthy adults in Belgium

Source
The journal of infectious diseases - ISSN 0022-1899-226:2 (2022) p. 287-291
Author(s)
    Elizabeth B. Brickley, Ruth, I. Connor, Wendy Wieland-Alter, Joshua A. Weiner, Margaret E. Ackerman, Minetaro Arita, Chris Gast, Ilse De Coster, Pierre van Damme, Ananda S. Bandyopadhyay, Peter F. Wright